Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Klingebiel

Showing results (1-10 of 295) with videos related to

Pageof 30
Sort By:
Deutsches Arzteblatt International|January 6, 2010
The price of hope: is autologous cord blood storage necessary and useful?Thomas Klingebiel
The Lancet. Oncology|July 30, 2013
Role of purging in PBSC transplantation for neuroblastomaThomas Klingebiel
The Lancet. Oncology|January 8, 2020
A new standard of care for patients with high-risk rhabdomyosarcoma?Ewa Koscielniak, Thomas Klingebiel
The Lancet. Oncology|June 27, 2024
Randomised trials in children with rhabdomyosarcoma: time for a change?Ewa Koscielniak, Thomas Klingebiel
Der Internist|May 5, 2021
[CAR T-cell therapy for children and adolescents with acute lymphatic leukemia]Peter Bader, Thomas Klingebiel
Pharmazie in Unserer Zeit|July 31, 2012
[Stem cell transplantation for acute leukemias: Balancing risks and benefits of different treatment methods]Thomas Klingebiel, Peter Bader
Cancer|February 7, 2025
Toward a reduction in the burden of therapy in patients with rhabdomyosarcoma: How much is enough?Ewa Koscielniak, Thomas Klingebiel
Blood|February 2, 2013
Peripheral blood stem cells versus bone marrow in pediatric unrelated donor stem cell transplantationRoland Meisel, Thomas Klingebiel, Dagmar Dilloo, et al.
Frontiers in Oncology|February 14, 2013
Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipientsThomas Lehrnbecher, Stanislaw Schmidt, Lars Tramsen, et al.
Blood|May 17, 2002
CD34 stem cell dose and development of extensive chronic graft-versus-host diseaseRupert Handgretinger, Peter Lang, Thomas Klingebiel, et al.
Pageof 30

Showing results (1-10 of 295) with videos related to

Sort By:
Pageof 30
Deutsches Arzteblatt International|January 6, 2010
The price of hope: is autologous cord blood storage necessary and useful?Thomas Klingebiel
The Lancet. Oncology|July 30, 2013
Role of purging in PBSC transplantation for neuroblastomaThomas Klingebiel
The Lancet. Oncology|January 8, 2020
A new standard of care for patients with high-risk rhabdomyosarcoma?Ewa Koscielniak, Thomas Klingebiel
The Lancet. Oncology|June 27, 2024
Randomised trials in children with rhabdomyosarcoma: time for a change?Ewa Koscielniak, Thomas Klingebiel
Der Internist|May 5, 2021
[CAR T-cell therapy for children and adolescents with acute lymphatic leukemia]Peter Bader, Thomas Klingebiel
Pharmazie in Unserer Zeit|July 31, 2012
[Stem cell transplantation for acute leukemias: Balancing risks and benefits of different treatment methods]Thomas Klingebiel, Peter Bader
Cancer|February 7, 2025
Toward a reduction in the burden of therapy in patients with rhabdomyosarcoma: How much is enough?Ewa Koscielniak, Thomas Klingebiel
Blood|February 2, 2013
Peripheral blood stem cells versus bone marrow in pediatric unrelated donor stem cell transplantationRoland Meisel, Thomas Klingebiel, Dagmar Dilloo, et al.
Frontiers in Oncology|February 14, 2013
Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipientsThomas Lehrnbecher, Stanislaw Schmidt, Lars Tramsen, et al.
Blood|May 17, 2002
CD34 stem cell dose and development of extensive chronic graft-versus-host diseaseRupert Handgretinger, Peter Lang, Thomas Klingebiel, et al.
Pageof 30